simvastatin has been researched along with Chondrosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cecen, B; Keles, D; Kozaci, LD; Oktay, G | 1 |
| Ishiguro, N; Knudson, W; Kojima, T; Takahashi, N; Takemoto, T; Terabe, K | 1 |
2 other study(ies) available for simvastatin and Chondrosarcoma
| Article | Year |
|---|---|
Effects of simvastatin on matrix metalloproteinase regulation in IL-1β-induced SW1353 cells.
Topics: Anti-Inflammatory Agents; Cell Line, Tumor; Cell Survival; Chondrocytes; Chondrosarcoma; Cytotoxins; Dose-Response Relationship, Drug; Gene Expression Regulation; Humans; Interleukin-1beta; Matrix Metalloproteinases; Simvastatin; Tissue Inhibitor of Metalloproteinases | 2019 |
Simvastatin inhibits CD44 fragmentation in chondrocytes.
Topics: ADAM10 Protein; Amyloid Precursor Protein Secretases; Animals; Cartilage, Articular; Cattle; Cell Line, Tumor; Cell Membrane; Cholesterol; Chondrocytes; Chondrosarcoma; Gene Expression Regulation; Humans; Hyaluronan Receptors; Interleukin-1beta; Membrane Microdomains; Membrane Proteins; Mevalonic Acid; Oncostatin M; Polyisoprenyl Phosphates; RNA, Small Interfering; Sesquiterpenes; Simvastatin | 2016 |